Heptares Therapeutics Companies
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).
Headquarters:
United Kingdom
Founded Date:
2007
Number Of Exists:
N/A
Employee Number:
11-50
Industry:
Longevity FinTech